Futura Medical Share News (FUM)

EARNINGS AND TRADING: Everyman Media loss widens; Kooth back in profit

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

After bumper 2024, Futura warns of lower 2025 sales on slow US uptake

(Alliance News) - Futura Medical PLC on Friday said it expects 2024 revenue and post-tax profit ahead of guidance, but warned of 2025 sales below market expectations, due to slow uptake in the US of its erectile dysfunction treatment.

AIM WINNERS & LOSERS: Kromek wins deal; Futura Medical warns on profit

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.

IN BRIEF: Futura gets good results for female sexual dysfunction aid

Futura Medical PLC - Guildford, Surrey-based sexual health products - Shares rise 4.5% on Wednesday as Futura reports positive results from a 'sensory' study of its WSD4000 treatment for sexual dysfunction in women. Futura explains that a sensory study assesses how healthy volunteers perceive product characteristics through their senses. The study involved 67 women with some degree of sexual dysfunction, and WSD4000 produced a positive change in a majority of them after four weeks. "Following the success of the study, alongside market research on the size of the opportunity following commercialisation, the board is recommending to proceed with an early feasibility study during H1 2025," Futura says.

Futura Medical reports progress with R&D pipeline

(Sharecast News) - Futura Medical announced encouraging progress in its product development pipeline on Monday, with successful proof-of-concept results for two new treatments addressing sexual dysfunction.

Futura Medical progresses study of female sexual dysfunction treatment

(Alliance News) - Futura Medical PLC on Monday said it has progressed the development of its new product pipeline, including treatments for sexual dysfunction in both men and women.

Futura Medical due $5m milestone payment from Haleon

(Sharecast News) - Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been triggered under its agreement with consumer products giant Haleon.

IN BRIEF: Futura Medical US pre-orders trigger milestone payment

Futura Medical PLC - Surrey-based sexual health products company - Announces that the next milestone payment of USD5.0 million, due under its agreement with Haleon PLC, has been triggered by Haleon's distribution of online pre-orders and the availability of Eroxon in US retailers. Eroxon is a fast-acting gel used to treat erectile dysfunction, which has been available without a prescription in UK pharmacies since March last year. Futura Medical struck a licensing deal with Haleon for the gel in July 2023, which has led to its availability in the US from October this year. Futura Medical expects to receive the payment from Haleon shortly.

EARNINGS AND TRADING: Blackbird loss narrows; Futura Medical in profit

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

UK earnings, trading statements calendar - next 7 days

Eroxon US sales a "significant opportunity" for Futura Medical

(Alliance News) - Futura Medical PLC offers "significant upside potential", an analyst on Monday said, after the firm confirmed Eroxon was available for pre-order online in the US.

IN BRIEF: Futura Medical's Eroxon to be available in US from October

Futura Medical PLC - sexual health products company - Says Eroxon is available for pre-order online, and will also be available in US stores from October. Eroxon is a fast-acting gel used to treat erectile dysfunction, which has been available without a prescription in UK pharmacies since March last year. More recently, Futura struck a licensing deal with Haleon PLC for the gel, which has led to its availability in the US.

CORRECT: LONDON MARKET MIDDAY: FTSE 100 fails to shake off China PMI

(Correcting that US financial markets will be closed for Labor Day.)

LONDON MARKET MIDDAY: FTSE 100 fails to shake off China despite PMI

(Alliance News) - Stock prices in London were red at midday on Monday, taking a tumble even as data showed continued recovery for the UK manufacturing sector.

AIM WINNERS & LOSERS: Futura Medical gets boost from Haleon push in US

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.